Primary Care in the post-COVID-19 pandemic period: development of a Mobile Health Applicatio

Not Applicable

Recruiting

• Conditions: Arterial Hypertension; Diabetes Mellitus; C23.550.291.898

• Registration Number: RBR-45hqzmf
• Lead Sponsor: niversidade Federal de Viçosa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-23
• Last Update Posted: 29 May 2023
• Study Completion: 2023-11-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Age equal to or greater than 18 years; users of the Unified Health System (SUS); diagnosis of Arterial Hypertension (AH) and/or Diabetes Mellitus (DM); accompanied by the Family Health Strategy (ESF) teams

Exclusion Criteria

Age less than 18 years old; individuals with serious medical conditions; pregnant women; smoking volunteers; history of alcohol or drug abuse; bedridden; wheelchair users

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It was expected to find a reduction in the clinical values of glycated hemoglobin in 6 months after the intervention, verified through the performance of biochemical tests and from the verification of a variation of at least 10% in the pre- and post-intervention measurements.;It was expected to find a reduction in blood pressure levels 6 months after the intervention, verified by measuring blood pressure and from the observation of a variation of at least 10% in pre- and post-intervention measurements.

Secondary Outcome Measures

Name	Time	Method
Evaluate the changes in anthropometric measurements (body weight, abdominal and calf circumference) in 6 months after the intervention, which will be verified with the aid of a scale and a body measuring tape and from the verification of a variation of at least 5 % in pre- and post-intervention measures.